St Andrews Pharmaceutical Technology Revenue
Biotechnology Research • 
St Andrews, Scotland, United Kingdom • 1-10 Employees
$
St Andrews Pharmaceutical Technology revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at St Andrews Pharmaceutical Technology
William Henry
Research and Development Director
Company overview
| Headquarters | 35 North Street, St Andrews, Fife KY16 9AQ, GB |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
About St Andrews Pharmaceutical Technology
Pulzar Technology is a unique patented technology that is based on micro-pulses of radio waves. Pulzar promotes an enhanced cellular metabolism that favours increased protein production.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
St Andrews Pharmaceutical Technology has never raised funding before.
Switzerland
United States
NetherlandsFrequently asked questions
St Andrews Pharmaceutical Technology is located in St Andrews, Scotland, GB.
St Andrews Pharmaceutical Technology generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.
St Andrews Pharmaceutical Technology has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
St Andrews Pharmaceutical Technology was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.
St Andrews Pharmaceutical Technology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
